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ABSTRACT 
The transcription factors Bcl6 and Blimp1 have opposing roles in the development of the 
follicular helper T (TFH) cells: Bcl6 promotes and Blimp1 inhibits TFH-cell differentiation. 
Similarly, Bcl6 activates, while Blimp1 represses, expression of the TFH-cell marker PD-1. 
However, Bcl6 and Blimp1 repress each other’s expression, complicating the interpretation 
of the regulatory network. Here we sought to clarify the extent to which Bcl6 and Blimp1 
independently control TFH-cell differentiation by generating mice with T-cell specific deletion 
of both Bcl6 and Blimp1 (double conditional KO [dcKO] mice). Our data indicate that Blimp1 
does not control TFH-cell differentiation independently of Bcl6. However, a population of T 
follicular regulatory (TFR) cells developed independently of Bcl6 in dcKO mice. We have also 
analyzed regulation of IL-10 and PD-1, two genes controlled by both Bcl6 and Blimp1, and 
observed that Bcl6 regulates both genes independently of Blimp1. We found that Bcl6 
positively regulates PD-1 expression by inhibiting the ability of T-bet/Tbx21 to repress Pdcd1 
transcription. Our data provide a novel mechanism for positive control of gene expression by 
Bcl6, and illuminate how Bcl6 and Blimp1 control TFH-cell differentiation. 
Graphical Abstract 
The transcriptional repressors Bcl6 and Blimp1 have complex and opposing roles in controlling 
follicular helper T (TFH)-cell differentiation and PD-1 expression. Xie et al show that Bcl6 
controls TFH-cell differentiation and PD-1 expression independently of Blimp1, while Blimp1 
regulates TFH-cell differentiation primarily by repressing Bcl6. 
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Introduction 
T follicular helper (TFH) cells promote formation of germinal centers (GCs) and select 
B- cell clones that produce high-affinity antibodies (Abs) (reviewed in [1, 2]). While TFH cells 
are required for the production of high affinity Abs, excessive numbers of TFH cells can 
promote autoimmunity by helping B cells produce self-reactive Abs.  The proper regulation of 
TFH cell differentiation is therefore essential for strong antibody responses and preventing 
development of autoimmune disease.   
The Bcl6 transcriptional repressor protein is considered a master regulator for the TFH 
lineage [3-5], however the precise mechanisms by which Bcl6 promotes TFH cell 
differentiation have not been fully elucidated. One pathway for TFH cell differentiation is that 
Bcl6 represses transcription of the transcriptional repressor Blimp1, a potent inhibitor of TFH 
cell differentiation [1, 5-8]. However, the mechanism by which Blimp1 itself represses TFH cell 
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differentiation is not settled. Blimp1 may inhibit TFH cell differentiation by directly repressing 
Bcl6 expression [5, 9, 10], or by repressing other genes that are critical for TFH cell 
differentiation besides Bcl6.  
Mice deficient in Bcl6 or Blimp1 have not provided a clear answer as to the 
relationship between of Blimp1 and Bcl6 in the development of TFH cells [5, 11]. Using 
conditional knockout (cKO) mouse models, researchers have shown that loss of Bcl6 in T 
cells results in complete loss of TFH cell development, while, conversely, Blimp1 cKO mice 
have increased TFH cell populations.  
A key TFH cell gene controlled by both Bcl6 and Blimp1 is PD-1. Bcl6 promotes PD-1 
expression [12], and Blimp1 represses PD-1 [13]. Since Bcl6 is a transcriptional repressor, 
the mechanism that Bcl6 uses to up-regulate PD-1 expression is likely to be an indirect 
pathway, such as by repressing the transcription of Blimp1.  
In this study, we used cKO mice doubly deficient for both Bcl6 and Blimp1 in T cells 
to delineate the respective roles of these two key factors in TFH cell differentiation and PD-1 
gene expression. Our results indicate that Bcl6 promotes both TFH cell differentiation and 
PD-1 expression by pathways essentially independent of Blimp1. 
Results and Discussion 
TFH cells but not TFR cells are dependent on Bcl6 for their development.  
To analyze TFH cell differentiation when both Bcl6 and Blimp1 were deleted 
specifically in T cells, we generated CD4-cre Bcl6fl/fl Prdm1fl/fl (dcKO) mice. These mice were 
healthy and T cell development was normal (data not shown).  We immunized the mice with 
sheep red blood cells (SRBC), and after 14 days, analyzed TFH cells in spleen (Fig. 1AB, 
Supporting Information Fig. 1A). Control (Con) mice were Bcl6fl/fl Prdm1fl/fl without CD4-cre. 
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Bcl6 cKO and Blimp1 cKO mice were also analyzed. Compared to Con, TFH cell populations 
were increased 2-fold in Blimp1 cKO mice, while TFH cells were completely absent in Bcl6 
cKO and dcKO mice. These data indicate that Bcl6 is required for TFH cell development even 
in the absence of Blimp1-mediated repression. Next, we analyzed the development of T 
follicular regulatory cells (TFR cells) [14-17] after SRBC immunization (Fig. 1CD, Supporting 
Information Fig. 1A). Blimp1 cKO mice have a sharply enhanced TFR cell population 
compared to Con mice, while TFR cells are nearly absent in Bcl6 cKO mice. However, TFR 
cells are significantly higher in dcKO mice than Bcl6 cKO mice, indicating that Blimp1 
represses TFR cells independent of Bcl6, and that TFR cells and TFH cells have somewhat 
different modes of development. We also analyzed GC B-cells by flow cytometry in the same 
sets of mice (Fig. 1EF, Supporting Information Fig. 1B), and GC B-cell development 
paralleled TFH cell development in all 4 mouse lines. SRBC-specific IgG titers followed the 
levels of germinal center B (GCB) cells (Supporting Information Fig. 2). We analyzed TFH 
cells, TFR cells and GCB-cells 7 days after SRBC immunization, and observed the same 
pattern as after 14 days (data not shown).  
 
Bcl6 controls PD-1 expression independent of Blimp1.  
Bcl6 and Blimp1 have opposing roles in PD-1 expression [12, 13], and we therefore 
analyzed PD-1 expression in immunized Con, Bcl6 cKO, Blimp1 cKO and dcKO mice (Fig. 
2).  The average level of PD-1 expression measured by mean fluorescent intensity (MFI) in 
total CD4 T cells showed very high PD-1 in CD4 T cells from Blimp1 cKO mice (Fig. 2A, 
Supporting Information Fig. 3A), consistent with Blimp1 repressing PD-1 expression. Since 
PD-1 expression in dcKO CD4 T cells is much lower than in Blimp1 cKO CD4 T cells, this 
indicates a positive role for Bcl6 in PD-1 regulation. Since the PD-1 levels on total CD4 T 
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cells are skewed by the presence of PD-1high expressing TFH cells, we analyzed PD-1 
expression on PD-1+ non-TFH cells (Fig. 2B, Supporting Information Fig. 3B). Loss of Blimp1 
again increased PD-1 in non-TFH cells whereas PD-1 in Bcl6 cKO and dcKO non-TFH cells 
was similar as control (Con) levels. These data indicate that the higher PD-1 in Blimp1 cKO 
non-TFH cells requires Bcl6 expression, but did not answer whether Bcl6 could regulate PD-1 
independently of Blimp1. To address this question, we used retroviruses (RVs) to express 
Bcl6 in activated CD4 control and dcKO T cells, then assessed PD-1 expression. As shown 
in Figure 2C (Supporting Information 3C), Bcl6 significantly augmented PD-1 expression as 
measured by MFI, in both control and dcKO T cells, showing clearly that Bcl6 could activate 
PD-1 expression independent of Blimp1. Indeed, Bcl6 induced higher expression of the 
Pdcd1 gene (Supporting Information Fig. 4A), whereas a known Bcl6 target, Il10 [11, 18] 
was strongly repressed by Bcl6 RV (Fig. 4B). Thus, Bcl6 can both activate and repress gene 
expression, independently of Blimp1. Since Blimp1 has been shown to positively regulate IL-
10 [19], our data also rules out a mechanism of IL-10 control where Bcl6 acts on IL-10 by 
repressing Blimp1 and causing decreased Il10 transcription, and shows that Bcl6 is a direct 
repressor of Il10 expression.  
 
A T-bet-dependent mechanism for the activation of PD-1 expression by Bcl6 
We next sought to find the mechanism for how Bcl6, a transcriptional repressor, 
could promote Pdcd1 mRNA expression independent of Blimp1. One explanation is that Bcl6 
represses the transcription of microRNAs that silence PD-1 expression [3]. We therefore 
tested the role of microRNAs in the induction of PD-1 by Bcl6, and found that Bcl6 RV could 
still up-regulate PD-1 in Dicer cKO T cells, which are unable to generate microRNAs 
(Supporting Information Fig. 5). We then sought other pathways. T-bet is a transcriptional 
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repressor of PD-1 gene expression [20], and Bcl6 is a negative regulator of T-bet [21]. 
Therefore we wondered if a T-bet-Bcl6 pathway could play a role in PD-1 expression in CD4 
T cells. We tested this idea by transducing primary mouse CD4 T cells with T-bet-expressing 
RV, with and without Bcl6 RV. As shown in Figure 3A, T-bet RV can significantly repress 
PD-1 expression compared to control RV, whereas addition of Bcl6 RV allows for PD-1 
activation even in the presence of T-bet RV. To further investigate this pathway, we 
analyzed PD-1 expression in Tbx21-/- (Tbx21 KO or T-bet-deficient) CD4 T cells and as 
expected, saw higher PD-1 in T-bet KO T cells compared to wild-type T cells (Fig. 3B). 
Notably, Bcl6 RV was able to strongly activate PD-1 expression in wild-type T cells (~50% 
increase in MFI) but Bcl6 RV was only able to activate PD-1 relatively weakly in T-bet KO T 
cells (~20% increase in MFI)(Fig. 3BC). These data indicate that a major pathway for the up-
regulation of PD-1 expression by Bcl6 is by counteracting the repressive action of T-bet on 
PD-1 expression.   
Concluding Remarks 
In summary, we have clarified several aspects of Bcl6 control over TFH cell and TFR cell 
differentiation (see model in Supporting Information Fig. 6). Specifically, we have found that: 
1) Blimp1 primarily represses TFH cell differentiation by acting on Bcl6, 2) Blimp1 represses 
TFR cell differentiation through both Bcl6-dependent and Bcl6-independent pathways and 3) 
Bcl6 promotes PD-1 expression by a novel Blimp1-independent mechanism involving T-bet 
inhibition. 
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Materials and Methods 
Mice and immunizations 
Bcl6fl/fl mice [11] were backcrossed to CD4-cre transgenic mice [22] and the C57BL/6 strain 
for at least six generations and then crossed to Prdm1fl/fl mice [23, 24]. Tbx21-/- mice were 
obtained from Jackson labs. Mice were bred under specific pathogen-free conditions at the 
laboratory animal facility at IUSM and were handled according to protocols approved by the 
IUSM Animal Use and Care Committee. For immunization, mice were injected 
intraperitoneally (i.p.) with 1 x 109 SRBCs (Rockland Immunochemicals) and sacrificed at the 
indicated day.    
 
Flow cytometry reagents 
Anti-CXCR5 (2G8) and GL7 (GL7) Abs were from BD Biosciences. Fixable viability dye, anti-
CD38 and anti-Foxp3 (FJK-16s) Abs were from eBioscience. Anti-CD4 (GK1.5), anti-B220 
(RA3-6B2), anti-IgG1 (RMG1-1), anti-PD-1 (29F.1A12) were from Biolegend. 
 
Cell staining for flow cytometry 
After red blood cell lysis, total spleen cells were incubated with anti-mouse CD16/CD32 
(BioXcell) for 5 minutes at RT, followed by surface staining for the indicated markers. For 
intracellular transcription factor staining, after surface markers were stained, cells were fixed 
and stained with antibodies against transcription factors by following Foxp3 fixation kit 
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(eBioscience) instructions. Cell events were collected on an LSRII flow cytometer (Becton 
Dickonson). 
 
Cell culture and retrovirus transduction 
CD4 T cells were isolated from the spleen via isolation kit (Miltenyi Biotec). Cells were 
activated with plate-bound anti-CD3 (10 μg/ml; 145-2C11; Bio XCell) and anti-CD28 (10 
μg/ml; 37.51; Bio XCell) for 24 h at 1 X 106 cells/ml. Cells were then spin-infected with 
control GFP, Bcl6-GFP–expressing [25] retroviruses (RVs). For co-infection experiments, 
either control H2Kk or Bcl6-H2Kk-expressing [26] RVs were co-transduced with either control 
GFP or T-bet-GFP–expressing [27] RVs. After infection, supernatants were substituted with 
fresh medium containing 10 U/ml recombinant human IL-2. Two days later, cells were 
collected for analysis.  
 
RT-QPCR and Antigen-specific IgG Analysis 
These procedures were performed as previously reported [28].  
 
Statistical Analysis. 
All data analysis was done using Prism Graphpad software.  Unless otherwise stated, 
Student t test or ANOVA with Tukey post hoc analysis were used. Only significant 
differences (P < 0.05) are indicated in Figures. 
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Figure legends 
Figure 1. Regulation of TFH cells, TFR cells and germinal center B cell by Bcl6 and 
Blimp1. Control, Blimp1 cKO, Bcl6 cKO and dcKO mice were immunized with SRBC by i.p. 
injection. 14 days post-immunization (dpi), spleens were isolated for flow cytometric 
analysis. TFH cells are defined as Foxp3
-CXCR5hiPD-1hi. TFR cells are defined as 
Foxp3+CXCR5hiPD-1hi. GC B cells are defined as B220+CD38loGL-7hi. (A) Representative 
flow cytometry plots, gated on FoxP3– CD4+ cells. (B) TFH-cell percentage within Foxp3
- 
CD4+ T cells and absolute TFH-cell number per spleen. (C) Representative flow cytometry 
plots, gated on Foxp3+ cells. (D) TFR-cell percentage in Foxp3
+CD4+ T cells and absolute 
TFR-cell number per spleen. (E) Representative flow cytometry plots. (F) GCB-cell 
percentage in B220+ B cells and absolute GCB-cell number per spleen. Flow cytometry plots 
are from a single experiment representative of 2 experiments with 16 total mice per 
experiment. Data in graphs are shown as mean ± SEM, n = 4 with each symbol representing 
a single mouse.  NS =not significant, p> 0.05, *p < 0.05 (two-way ANOVA). Data are 
representative of 2 independent experiments with similar results with 16 total mice per 
experiment.  
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Figure 2. Control of PD-1 expression by Bcl6 and Blimp1. Control, Blimp1 cKO, Bcl6 
cKO and dcKO mice were immunized with SRBC by i.p. injection. At 14 days dpi, spleens 
were isolated for flow cytometric analysis. (A) PD-1 mean fluorescence intensity (MFI) of 
total CD4+ T cells at 14 dpi (n=4, mean ± SEM). (B) PD-1 MFIs of CD44+ CXCR5- PD-1+ 
non-TFH cells. (C) Control and dcKO CD4+ T cells were infected with Bcl6-expressing and 
control retroviruses (RVs). **p < 0.01 (two-way ANOVA). Each symbol in graphs represents 
one mouse. Data are representative of two independent experiments with similar results with 
16 total mice per experiment.   
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Figure 3. Control of PD-1 expression by Bcl6 and Blimp1. Total CD4+ T cells from wild-
type (WT) or Tbx21 cKO mice were co-infected with Bcl6-H2Kk-expressing and T-bet-GFP-
expressing and control RVs. PE-labeled anti-H2Kk Ab was used to detect H2Kk expressing 
cells. Double GFP+PE+ cells were gated on for analysis. (A) PD-1 MFI of total CD4+ T cells 
from WT mice after control, Bcl6, T-bet or Bcl6 plus T-bet RV co-infection (n=4, mean ± 
SEM). (B) PD-1 MFI of total CD4+ T cells after control, Bcl6, T-bet or Bcl6 plus T-bet RV co-
infection. Statistical designations: * compares WT to Tbx21 KO, # compares WT with the 
different RV infections, @ compares Tbx21 KO with the different RV infections. (C) 
Percentage of increase of PD-1 MFI of total CD4+ T cells after control or Bcl6 RV infection in 
same experiment as (B). ***, @@@, ### = p < 0.001, **=p < 0.01 (t test). Data are 
representative of two independent experiments with similar results, and with 4 mice per 
condition per experiment. 
 
